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Abstract 
Significance. Oxidative stress is thought to account for aberrant redox homeostasis and 
contribute to aging and disease. However, more often than not administration of antioxidants 
is ineffective, suggesting our current understanding of the underlying regulatory processes is 
incomplete. Recent Advances. Similar to reactive oxygen and nitrogen species (ROS, 
RNS), reactive sulfur species (RSS) are now emerging as important signaling molecules, 
targeting regulatory cysteine redox switches in proteins, affecting gene regulation, ion 
transport, intermediary metabolism and mitochondrial function. To rationalize the complexity 
of chemical interactions of reactive species with themselves and their targets and help 
define their role in systemic metabolic control, we here introduce a novel integrative concept 
coined the reactive species interactome (RSI). The RSI is a primeval multi-level redox-
regulatory system whose architecture, together with the physicochemical characteristics of 
its constituents, allows efficient sensing and rapid adaptation to environmental changes and 
various other stresses to enhance fitness and resilience at the local and whole-organism 
level. Critical Issues. To better characterise the RSI-related processes that determine 
fluxes through specific pathways and enable integration, it is necessary to disentangle the 
chemical biology and activity of reactive species (including precursors and reaction 
products), their targets, communication systems and effects on cellular, organ and whole-
organism bioenergetics using systems-level/network analyses. Future Directions. 
Understanding the mechanisms through which the RSI operates will enable a better 
appreciation of the possibilities to modulate the entire biological system; moreover, unveiling 
molecular signatures that characterize specific environmental challenges or other stresses 
will provide new prevention/intervention opportunities for personalized medicine. 
Keywords: Hydrogen sulfide, polysulfides, nitric oxide, systems biology, microbiome, 
network medicine  
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1. Introduction 
Nothing in biology makes sense except in the light of evolution. 
Theodosius Dobzhansky 
 
Life is nothing but an electron looking for a place to rest. 
Albert Szent-Györgyi 
We are witnessing an unprecedented paradigmatic change in the practice of 
medicine whereby the concept of intervention is evolving from treating diseases in a one-
organ/one-symptom fashion to a systems-based approach that considers a patient’s 
pathophysiological condition including his/her individual genetic blueprint, microbiome, 
disease history and life-style. Indeed, diseases presenting with similar clinical phenotypes 
are often heterogeneous conditions of multifactorial origin, involving a multitude of 
molecular, cellular and organ systems. Their multilevel nature and complexity pose a 
formidable challenge to identifying the molecular causes; finding the most suitable therapy 
for each specific case demands a thorough understanding of the fundamental principles of 
biological regulation and a refined inter-disciplinary systems approach encompassing 
medicine, pharmacology, biology, chemistry and physics. Recent analyses indicate the 
existence of disease-specific functional modules that are central hubs in the vast network of 
human diseases y, offering additional opportunities by embracing mathematical approaches. 
A limited number of risk factors (such as poor-quality nutrition or physical inactivity) 
and chronic conditions (including hypertension, cardiovascular disease, obesity, asthma, 
diabetes, neurodegenerative diseases and certain forms of cancer) account for the majority 
of the global burden of disease (114), overall life expectancy and all-cause mortality (203). A 
common feature of many of these conditions is oxidative stress (176), and some have been 
re-defined as “redox diseases” (26,206). The term oxidative stress was originally described 
as “an imbalance between oxidants and antioxidants in favor of the oxidants, leading to a 
disruption of redox signaling and control and/or molecular damage” (91,174); it was initially 
considered to be triggered by an inflammatory process or mitochondrial dysfunction. 
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However, the use of selective antioxidants for redox diseases has not had the effect 
anticipated, suggesting that our current understanding of the underlying pathophysiological 
processes is incomplete (26,176). 
Recently, Jones and Sies proposed that besides the Genetic Code, allowing 
reproduction and defining heredity, there exists a Redox Code1 that identifies the regulatory 
elements and defines the principles through which biological function is enabled and 
rotected (94).  Within this concept, the endogenous production of reactive oxygen species 
(ROS) is a highly regulated enzymatic process, which serves the purpose of signaling and 
an lead to the modification of cysteine redox switches. Modification of these switches leads 
to modulation of their functional state, which would result in alterations of protein structure, 
enzymatic activity or gene transcription. Modifying responses to match a changed 
nvironment creates the opportunity for adaptive changes that enhance an organism’s 
fitness for purpose. 
However, there is more to this redox network than ROS. Nitric oxide (NO) is a free 
radical, which is produced endogenously by NO synthases (NOS) and acts as an effector 
and messenger, regulating a variety of physiological processes. Chemical interactions of NO 
with ROS form reactive nitrogen species (RNS) constitute the basis for the formation of a 
multitude of additional oxidative signaling elements (65), including the highly reactive and 
potentially damaging peroxynitrite (ONOO-). Both ROS and RNS may target cysteine thiols 
leading to oxidative modifications (including formation of sulfinic acid, sulfenic acids and thiyl 
radicals, and sulfane-sulfur containing molecules, such as persulfides and polysulfides) 
(131,132,140). By analogy to ROS and RNS, these compounds are identified as reactive 
sulfur species (RSS) (67). Similar to ROS and RNS, RSS were first considered to be 
produced only under pathological conditions and not recognized as being involved in 
                                               
1 In this context, the word „code“ is used to describe a “set of principles“, rather than a carrier of 
information like in the genetic code.  
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signaling functions. More recently, hydrogen sulfide (H2S) and its sulfane-sulfur derivatives 
have been shown to participate in fundamental biochemical pathways that control cellular 
redox homeostasis, signaling, metabolism, and mitochondrial function (145,204), perhaps 
most intriguingly illustrated by the ‘suspended animation’ observed after H2S inhalation in 
small rodents (11). This has led to a renewed interest in sulfide chemistry and biology 
(37,38,104,126,187), and RSS, together with ROS and RNS, to be considered as important 
physiological signaling molecules. 
The view that placed oxygen at the centre of the redox-regulatory system has been 
questioned recently by the realization that much of the evolutionary biology of Life evolved in 
a sulfur-rich atmosphere virtually free of oxygen (135,139). Indeed, it is considered likely that 
the interaction of RSS with RNS to form S/N-hybrid species participated in forming the 
building blocks of Life and preceded the advent of aerobic respiration and ROS formation 
(41). In this model, as the level of atmospheric oxygen rose, enabling the development of 
larger and more energy-efficient organisms, the ancient mechanisms of sulfur metabolism 
ad to face the new challenge of dealing with rapid oxidation processes superimposed onto 
those that controlled electron transfer in all life forms until then. This model helps to explain 
why many regulatory pathways are connected to fundamental sulfur-mediated electron 
transfer processes. As the levels of complexity increased from unicellular to larger 
multicellular organisms, the fundamental principles of regulation were conserved. 
In this review we provide an integrative biology concept of redox regulation (Fig. 1). 
We here define the chemical interaction of RSS, RNS and ROS among themselves and with 
downstream biological targets as the reactive species interactome (RSI) (Box 1). We 
propose that the RSI serves an integrative function to sense multiple stressors and adjust 
bioenergetic/metabolic needs accordingly by activating downstream effector pathways to 
ensure the organism is able to respond to environmental change and stay fit for purpose 
(Box 2 and Fig. 1). Within this model, H2S along with other thiols is considered an important 
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source of RSS, which have a critical role in enabling and supporting this complex cell 
signaling network.  
The current review discusses how 1. the RSI evolved and contributed to shape 
evolution; 2. the chemistry of the RSI is linked to the cysteine-based redox switches/relays, 
enabling sensing and transduction of stress signaling for short- and long-term adaptation; 3. 
precursor/cofactor availabilities due to changes in intermediary metabolism affect the RSI; 
4. a systems-level analysis of these redox signaling elements can contribute to our 
understanding of fundamental biology and (patho)physiology; and how 5. embracing redox 
biology in clinical practice and public health can help explain variability in response and 
thereby contribute to the development of more appropriate sensitive and specific and 
preventive or therapeutic interventions. 
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2. How it all began: Evolution of the reactive species 
interactome. 
Life began nearly 4 billion years ago (bya), and approximately 85% of all ensuing 
evolution occurred under anoxic or extremely hypoxic conditions. Rather than oxygen, two 
other gases, H2S and NO, were present in the early atmosphere and arguably shaped the 
ulk of the evolution of life on Earth.  
Two decades ago, a case was made that NO production by simple life forms may 
have provided a crucial survival mechanism against ROS at the time of emergence of 
aerobic life, offering an opportunity for its further utilization as an early signaling molecule 
(56). Intriguingly, the story of reactive species may have started much earlier. Indeed, more 
recently H2S has been implicated in the origin of Life (139). The following section places 
mphasis on the role of sulfur in the evolution of redox metabolic systems, how at a later 
stage O2 replaced some of the roles of sulfur as donor and acceptor of electrons for energy 
metabolism and signaling, and how reactive species may have contributed to the evolution 
of Life by enabling environmental sensing, metabolic plasticity, and cell-cell communication.  
Comparisons with other life origin theories, e.g., the hydrogen hypothesis, the RNA world 
and panspermia are beyond the scope of this article. For a more comprehensive treatise of 
how the emerging field of ‘systems chemistry’ has shaped our understanding of the origin 
of Life and that of metabolism, and the fundamentals of biochemical adaptation the reader is 
referred elsewhere (20,80,149). 
2.1 Prebiotic primordial interactions – Generating the building blocks of Life  
Life requires a set of essential molecular building blocks from which to assemble 
more complex structures, enzymes to direct these processes, membranes to partition 
simultaneously occurring events, and energy to overcome inherent entropies (Box 3). The 
building blocks of Life comprise inorganic or organic precursors of RNA, DNA and proteins 
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which, it is proposed, were derived from either intense electrical discharge in a “primordial 
soup” containing basic elements such as carbon, sulfur and nitrogen (125), atmospheric 
photochemical reactions (158), extraterrestrial sources ranging from collisions with massive 
objects (22,147) to the fine interstellar dust (which continues to add a large amount of 
organic compounds to Earth on a daily basis (9)), or through volcanic activity and 
hydrothermal fissures in the Earth’s crust.  However, as only the latter can provide a 
constant and reliable source of energy, it is most likely that Life emerged here (98,148). The 
Earth’s earliest atmosphere must have contained large amounts of H2S (198). Sulfide is an 
efficient reductant, and its chemical nature was fundamental for driving protometabolic 
reactions with N2 and CO2 to form RNA, amino acids, and lipid precursors (142). Our planet 
has been likened to a primordial reaction cell (148) where energy in the form of reducing 
quivalents, namely ferrous iron (Fe2+) and sulfide (H2S, HS-, S2-), traversed the Earth’s 
crust through pores (hydrothermal vents) at a steady, and therefore dependable rate. Many 
of these hydrothermal vents sit on massive sulfide deposits called sulfide lenses (168,169), 
where the magmatic flow heats the water to over 400°C. The combination of heat, water 
nd high-pressure drives organic synthesis not possible under other conditions, and as the 
water rises and cools the products become stable.  
An argument can be made for the primacy of sulfide in the origin of life: in 
combination with transition metals, especially iron, copper, zinc, molybdenum and tungsten, 
allowing 1 and 2-electron transitions, sulfides formed a variety of catalysts that were 
prototypical enzymes for organic synthesis and created a platform upon which synthesis 
could occur (33,163,200,201). These metal-sulfide minerals formed primordial “membranes”, 
allowing compartmentalization of parallel chemical reactions (122). Then, the constant flux of 
reducing equivalents into the comparatively oxidizing environment of seawater provided a 
continually renewed and reliable energy source. In addition, some oxidized sulfur coming 
from the vents gave rise to the formation of defined redox zones. 
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2.2 Evolution of Life – from sulfur to oxygen  
Life is likely to have begun around hydrothermal vents in a ferrungious (anoxic and 
Fe2+ rich) ocean approximately 3.8 bya (153,164) and it was chemolithotrophic, completely 
ependent upon the Earth for energy (Fig. 2). Within a surprisingly short time, 200-400 
million years, photosynthesis appeared, which allowed Life to become independent from 
Earth’s energy. The earliest light gathering antennae were not able to harvest enough light 
to oxidize water, and the process was anoxygenic. It has been proposed that an 
intermediate such as H2O2 was used as the initial electron donor (154). However, H2O2 
would have been in short supply, and it is more likely to have been H2S, H2S2 or a related 
sulfur species (Eq. 1), as seen in modern-day green and purple sulfur bacteria (62). 
 H2S + CO2 + hv –> Sn + CH4  [1] 
This reaction is important because H2S was plentiful and the enzymes that evolved to 
catalyze this reaction could be readily adapted to oxidize H2O once sufficient energy could 
be extracted from the sun. 
Oxygenic photosynthesis likely first appeared in cyanobacteria around 3 bya (Fig. 2). 
This ultimately led to the great oxidation event around 2.3 bya when atmospheric O2 is 
hought to have risen to 1-2%, which is 5-10% of present atmospheric levels (45,164). 
However, apart from small oxygen “oases” in the shallows the oceans remained anoxic. 
Although limited, atmospheric O2 slowly oxidized exposed elemental sulfur and dissolved 
H2S/HS- to sulfate, which was then carried to the oceans, reduced to H2S by the pervasive 
Fe2+ and, within a hundred million years, vast areas of ocean became euxinic (anoxic and 
sulfidic).  It was in this environment that endosymbiosis, in which a sulfur-reducing Archaea 
engulfed a sulfide-oxidizing α-protobacterium, produced the mitochondrion around 1.5 bya 
(111,165). These early eukaryotes would later incorporate cyanobacteria and thus become 
the ancestors of modern day plants. Combined oxygen production by cyanobacteria and 
primitive plants eventually oxidized all the oceanic iron and sulfide, and around 600 million 
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years ago atmospheric O2 began to increase to present-day levels (Fig. 2). This oxic 
environment is generally thought to have had dire consequences due to formation of 
hydroxyl radicals (HOy), H2O2, and superoxide (O2y−), collectively defined as ROS, (Eq. 2); 
 H2O (-e-) –> HO∙- (-e-) –> H2O2 (-e-) –> O2∙- (-e-) –> O2 [2] 
According to the OxTox hypothesis, organisms either had to develop antioxidant 
strategies (109), retreat to anoxic niches, or die.  But was it really this bad? 
2.3 Antioxidant defense or rather sulfur detoxifying strategies?  
Before the atmosphere enriched with O2, it is quite likely that the early anoxigenic 
photosynthesis (Eq. 3) initially evolved as stepwise one-electron oxidation of H2S; (Eq. 3); 
 H2S (-e-) –> HS∙- (-e-) –> H2S2 (-e-)–> S2∙- (-e-) –> S2(n)  [3] 
Thiyl radicals (HSy), disulfane (H2S2), and persulfide radicals (S2y-, “supersulfide”) thus 
generated can indeed be very reactive and are either potent oxidants or reductants (see 
section 3), collectively known as RSS.  
Like ROS, RSS could have had dire consequences: organisms either had to acquire 
detoxification capability for coping with RSS or die. These capabilities would have to be 
different from those found in anaerobic organisms, which could escape the oxygen by 
retreating to anoxic niches. For organisms carrying out anoxygenic photosynthesis retreating 
to asulfidic niches was not an option, as these did not exist. Therefore, safely disposing of 
RSS, or their use for signaling or further metabolism, must have enabled the acquisition of 
appropriate metabolic pathways long before oxygen became prevalent. This would explain 
why antioxidant systems like superoxide dismutase (catalyzing reduction of O2y−), catalase 
and glutathione peroxidase (catalyzing the reduction of H2O2), and the redox systems 
governed by thioredoxins, peroxiredoxins and glutaredoxins, all appeared with the advent of 
anoxigenic photosynthesis more than 2 bya before they would be called on to deal with ROS 
(21,103,124,137,221). Therefore, we suggest that – contrary to common belief (8) – these 
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systems evolved to detoxify RSS and/or to shuttle reducing equivalents for energy utilization 
r signaling. With the advent of O2 it would have been a relatively trivial matter to switch from 
dealing with RSS to ROS, as their biological chemistries present more similarities than 
differences. The use of multiple reactive species is in alignment with the need to keep the 
composition of the internal environment (Claude Bernard’s ‘milieu interieure’) relatively 
constant (83). 
2.4 RSI for sensing and metabolic plasticity  
The ready availability of energy in a usable form is a fundamental requirement for 
survival and reproductive success. In addition to defense and repair systems suitable to 
cope with harsh environmental conditions, in a world of finite resources organisms require 
metabolic flexibility to respond and adapt to changes in environmental conditions (Box 2). 
The capability of early life forms to adjust their energetic needs and metabolic capability to 
effectively respond to a variable availability of nutrients/precursors requires an ability to 
sense and respond to those changes. This would involve the capability to “sniff out” the 
prevailing conditions in the extracellular environment and adjust metabolic pathways 
accordingly. The metabolic plasticity required for this responsiveness in living organisms 
presumes the ability to securely cope with reactive species. Reactive species are formed 
mainly as enzymatic products from specific organic and inorganic substrates, including 
amino acids, nitrite, polysulfides, sulfite, sulfate, and O2 (as discussed in detail in section 4). 
The RSI captures the interaction at the interface between internal and external milieu that 
nabled metabolic plasticity of early, unicellular life forms, and persists in regulating the 
intersection of co-metabolism and pathogenesis in response to bacterial infection today 
(155). 
2.5 From monocellular to multicellular life forms  
The development of intercellular communication and the emergence of symbiotic 
arrangements provided new “collaborative” opportunities to cope with environmental and 
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infectious threats as well as nutritional shortages. As discussed for NO earlier (Box 3) (56), 
longer-lived RSI metabolites may later have participated in cell-cell communication and 
enabled co-metabolic negotiations. As levels of regulatory complexity within those multi-
cellular life forms increased, so did the need for communication. Yet, without appropriate 
protection these symbiotic life forms were still vulnerable to threats and dependent on 
opportunities provided by their local environment. Gaining independence and resilience 
against external stressors required formation of cell assemblies allowing robust growth and 
movement. This may have been a driver for the development of larger multicellular 
organisms with distributed critical functions and enhanced resilience. With redox processes 
at the heart of global regulation, all organisms larger than perhaps a few hundred cells would 
require an internal system to communicate metabolic activity status and perceived threat 
level throughout the entire system, allowing bioenergetic prioritization to survive and 
reproduce; in other words an inter-organ communication system (see Section 5 for further 
details).  
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3. The reactive species interactome: Sensing and 
transducing elements 
The rich chemistry of the RSI offers a unique opportunity to fine-tune biological 
reactions, taking advantage of the diverse chemical nature and lifetimes of the intermediary 
products formed. The interaction of RNS with ROS, exemplified by the formation of ONOO−, 
from O2y− and NO has been conceptualized in the form of the chemical biology of NO 
previously (65,190). ROS/RSS interaction leads to production of oxidized sulfur species, 
some of which can further react with biological targets, including cysteine thiolates, to 
generate e.g. persulfides. Much less is known about the interaction of RSS with RNS to 
generate S/N hybrid species. However, HSNO/SNO− and SSNO− are prominent examples 
(37-39) that, along with persulfides/polysulfides (37-39,41), garnered significant interest 
lately. Persulfides and S/N-hybrid species have a chemical biology with unique 
characteristics (37). The following section provides a brief overview of known interaction 
products of biological significance and discusses how their fundamental chemistry dictates 
their kinetics of formation, action radius and biological reactivity and how they are 
particularly fit-for-purpose in regulated biological systems (Box 3).  
3.1 The chemical biology of the RSI - Interaction of NO, H2S and O2 and derived 
species.  
It is becoming increasingly evident that the signaling and physiological functions of NO, H2S 
and O2 should be viewed as components of an integrated whole (219) since they have the 
potential to interact with each other and effect common biological targets. A comprehensive 
treatment of all the possible chemical/biochemical interactions between NO, H2S and O2 
(and derived species) and their potential interactions at common biological targets is an 
enormous undertaking and beyond the scope of this review; other, more comprehensive 
treatments are available (5,65). Therefore, the possible interactive nature between NO, H2S 
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and O2 will be discussed in very general terms. However, a more detailed emphasis on 
sulfide species will be given, because this is an area of significant current activity with 
understanding of much of the chemical biology of these functional groups coming to light 
only recently. 
Of all the small molecule bio-regulators, the chemical biology of O2 is clearly the most 
studied and established. As the ultimate electron acceptor for aerobic life, reduced O2 
species such as superoxide (O2y−), hydrogen peroxide (H2O2) and hydroxyl radical (HOy) are 
thought to be generated enzymatically and non-enzymatically, and possess biological 
relevance. Indeed, all have been proposed to serve as cell signaling agents and/or have 
pathophysiological consequences. All of these species have been grouped together under 
the somewhat misleading term ROS even though their reactivities are distinct, highly 
dependent on the cellular environment and potentially opposing. For the sake of brevity, it is 
probably best to categorize the different entities according to their predominant chemical 
attributes in tabular form (Tab. 2). 
Akin to the term ROS, the equivalent terms RNS and RSS denotes NO-derived and 
H2S/RSH-derived species. Undoubtedly, these terms can be equally misleading since the 
chemical reactivities of RNS and RSS are widely varying and distinct.  Regardless, the 
generation and predominant chemical properties of the RNS and RSS are also listed in Tab. 
2.  It is especially noteworthy that the interaction between ROS, RNS and RSS can lead to 
products with distinct (and even opposite) chemistry from that of the precursors. For 
xample, the reaction of NO with O2y −  to make peroxynitrite (ONOO −) takes two poor 
oxidants (NO and O2y−) and generates the potentially potent oxidant, ONOO−. As shown in 
ab. 2, ROS, RNS and RSS taken together cover a wide array of chemical properties 
ranging from highly reducing (RSSH, O2y − ) to highly oxidizing (HOy, NO2), from highly 
electrophilic (RSOH, H2O2, HNO) to highly nucleophilic (RSSH), and from good hydrogen 
atom donors (HNO, RSSH) to potent hydrogen atom abstractors (HO·, NO2).  This chemical 
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diversity allows Nature to take advantage of widely varying interactive chemistries provided 
by a limited number of biochemical precursors (namely O2, NO, H2S and derived species). 
The cellular conditions conducive to formation of these species implies a selective pressure 
towards systems that enable a high level of control together with the regulation of cellular 
function with appropriate biochemical transformations. For sensing/signaling purposes the 
biochemical syntheses of ROS, RNS and RSS must be tightly controlled kinetically, 
temporally and spatially. For example, NO biosynthesis can occur via three primary 
pathways involving NOS enzymes that are distinct with regards to their regulation and 
location (40,58). The generation of NO2 from NO is kinetically second order in NO and first 
rder in O2, indicating that significant NO2 levels (at least made via NO/O2 chemistry) can 
only be produced in compartments possessing high levels of both precursors such as lipid 
membranes (115). Of note, nitrogen oxide-modified lipids (containing nitrated fatty acids) 
possess potent biological activities (156). Moreover, significant generation of ONOO− 
requires that both NO and O2y −  be made at the same place, rate and time (96). This 
requirement makes ONOO− generation rather difficult, possibly protecting cells from 
inadvertent formation and narrowing its action radius.  
S-Nitrosothiol formation can occur in several ways (37,65). One possibility is the 
reaction of a free thiol with a nitrosating species, i.e. an entity that donates the equivalent of 
“NO+” such as N2O3.  Another possibility is the reaction of a thiyl radical with NO. 
Importantly, N2O3 generation is kinetically restricted (214) (for similar reasons as NO2 
generation); as a one-electron oxidant thiyl radical is very reactive, and its formation can 
only take place under very specific conditions, such as at the active site of enzymes like 
ribonucleotide reductase (184). These strict chemical requirements offer a selective 
advantage by limiting the generation of unwanted reactive and/or deleterious species, which 
ensures that they are only formed under specific conditions for a particular purpose. By 
contrast, inadvertent or aberrant generation of any ROS, RNS or RSS carries the risk of 
pathophysiological consequences.   
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Finally, RSS receiving considerable recent attention are hydropersulfides (RSSH).  
Generation of hydropersulfides from the corresponding thiol represents an oxidation (an 
RSSH species is at the same oxidation state as a disulfide, RSSR) and can be mediated by 
several of the oxidants listed in Table 2 (e.g. H2O2 in the presence of H2S). Interestingly, a 
hydropersulfide is a superior reductant compared to the corresponding thiol. Thus, an 
xtremely potent reductant (RSSH) is made primarily under oxidizing conditions, a fact that 
seems to have been taken advantage of in Nature as it has been proposed that RSSH 
formation can be protective against oxidative stress (140). 
Since RSS are relatively new players in the RSI some more space is allotted here to 
the discussion of these species.  
3.2 The chemistry of persulfides/polysulfides 
One of the most well established reactions of H2S in biochemistry is that with 
disulfides (10,60,140). Reaction of H2S with RSSR yields an equilibrated system involving 
the corresponding persulfide (RSSH) and thiol (RSH) species (Eq. 4). 
 
RSSH species display a unique chemistry that differs from that of RSH and H2S, 
conferring potential advantages in biology. 
In comparison to RSH, RSSH is both more nucleophilic and reducing. The greater 
nucleophilicity of RSSH can be explained by 1) the α-affect, in which the electrons of the 
internal sulfur atom repel those of the external sulfur atom, thus enhancing nucleophilic 
reactivity – a characteristic lacking in RSH and, 2) the pKa of RSSH typically being 1-2 units 
lower than analogous RSH species, making the anionic RSS− present in greater 
concentrations than RS− at physiological pH.  
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RSSH is also a more potent one- and two-electron reductant than RSH. The greater 
two-electron reducing ability of RSSH can be explained by its greater nucleophilic character. 
The fact that RSSH is a better one-electron reductant than RSH is explained by the stability 
of the corresponding perthiyl radical (RSS•) over that of the thiyl radical (RS•). Formation of 
RSS• leads to a resonance-stabilized unpaired electron (shown below) that does not exist for 
RS• (Eq. 5) 
  (5) 
Lastly and perhaps most intriguingly, RSSH are also electrophilic species whereas 
RSH are not. Consideration of the oxidation state of the sulfur atoms in RSSH reveals that 
each are both in a -1 oxidation state. By comparison, the oxidation state of the sulfur atom of 
RSH is -2 and therefore, RSSH is oxidized with respect to RSH. In this light, RSSH are 
similar to RSSR (in which both sulfur atoms are also in the -1 oxidation state) and thus, are 
also able to act as an electrophile. Indeed, the elctrophilic ability of RSSH is expected to be 
 function of pH, as the deprotonated RSS− species is considered to be less electrophilic 
(and more nucleophilic) than the protonated RSSH. Electrophilic reactivity of RSSH can yield 
H2S (via nucleophilic attack on the internal sulfur), or result in a transsulfuration process (via 
nucleophilic attack at the terminal sulfane-sulfur), yielding another RSSH species (Eq. 6) or 
inorganic polysulfides (i.e. HSSH; Eq. 7). 
  RSSH  +  R’SH   RSH  +  R’SSH  (6) 
  RSSH  +  H2S    RSH  +  H2S2  (7) 
3.3 S/N hybrid species 
Although several groups have investigated the interaction of RSH and nitrogen 
oxides, specifically NO, mechanisms for the formation of resulting species in biological 
systems are still controversial. Therefore, the possible reactions of RSH and other related 
R S S R S+ S-
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species with NO will be discussed here from a chemical standpoint and implications for 
biological relevance will be given based on this. As alluded to above, S-nitrosothiols have 
been reported to have important biological function and serve as biological signaling 
molecules (17,59,179). However, no direct reaction between RSH and NO should be 
expected to produce such RSNO species because NO has an unpaired electron that 
occupies an NO antibonding orbital, preventing nucleophilic attack by RSH. However, 
oxidation of RSH to the corresponding RS• allows for reaction with NO, yielding RSNO (Eq. 
8). 
                         (8) 
Other pathways leading to RSNO formation include RSH reaction with products from 
the reaction of O2 and NO (i.e. N2O3, Reaction 9), or by reaction with metal-nitrosyl 
complexes in which the NO ligand acts as a nitrosonium ion (i.e. Fe2+-NO+, Eq. 10).  For 
example, coordination of NO to a ferric iron species (Fe3+) can generate a ferric nitrosyl 
complex (Fe3+-NO; also described as {Fe(NO)}6 using the Enemark-Feltham notation for 
metal nitrosyls). This species can be viewed as having significant ferrous nitrosonium 
character (Fe2+-NO+) and thus can serve as a source of “NO+” when reacting with 
appropriate nucleophiles. 
 
  RSH  +  N2O3 Æ  RSNO  +  NO2-  +  H+  (9) 
  RSH  +  Fe2+-NO+  Æ  RSNO  +  Fe2+  +  H+ (10) 
 
Likewise, similar reactivity is predicted for HS− (in comparison to RSH), theoretically 
leading to formation of HSNO. For the same reasons as outlined for RSH above, no direct 
reaction between HS− and NO should occur to any significant extent. 
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Like RSH, RSSH is not expected to react directly with NO. Although one-electron 
xidation of RSSH to RSS• might be expected to yield the corresponding alkyl-S-
nitrosopersulfide (RSSNO) via reaction with NO, recent studies indicate this either does not 
occur to any great extent (10) or the product has a short lifetime (2). For this reason, 
RSSNO may not be expected to serve as a biological signaling molecule or NO transporter. 
Curiously (and unlike thiyl radicals), RSS• is rather stable even in the presence of O2 (10), 
offering potential opportunities for electron transfer reactions under aerobic conditions (see 
Section 5.3).  
 Contrary to the presumed instability/reversibility of RSSNO, SSNO− 2 (37) appears to 
be relatively stable (a result of the resonance-stabilized anion (10,120)), existing for 
extended periods of time even in the presence of other RSH species (39,41). Although 
SSNO− has been observed to form under various conditions including reaction of NO with 
H2S and polysulfides (HSSnH, n≥2) (41,120), the exact mechanism for SSNO− formation is 
unknown.  However, it is reasonable to consider that SSNO− is made via reaction of NO with 
trace polysulfide contaminants present in H2S sources. For example, presence of trace S2•− 
(a possible result of one-electron oxidation of S22− or homolytic cleavage of S42−), which is a 
species well recognized by sulfur chemists to exist in salt melts and heated non-aqueous 
solutions of sulfur (181), could be expected to react directly with NO, yielding SSNO− (37), 
(Eq. 10). 
  S2·-  +  NO   SSNO− (10) 
It should be noted however that to date, SSNO− has yet to be observed in a 
biological system, leaving its relevance and biological formation still uncertain. Nevertheless, 
pharmacological SSNO− has been shown to release NO, dilate blood vessels and activate 
the prototypical Nrf2 stress-response pathway (39,41,42).  
                                               
2 We here use the most traditional notation of perthionitrite (SSNO−), as the molecule was 
originally named by Seel et al (see reference 37 for a comprehensive review); however, the notation 
as nitrosopersulfide (ONSS−) is also correct.   
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3.4 Cysteine-based redox switches and redox relays 
Free sulfhydryl (-SH) groups in low-molecular-weight thiols such as cysteine, 
peptides (like GSH), and proteins (e.g. albumin) are predominant targets of RSI signal 
transduction; others include methionine, tryptophan, tyrosine, and histidine moieties, but 
their functional significance is not fully understood.  
Cysteines may serve structural, catalytic and regulatory functions in proteins and are 
considered redox switches as they are targeted for oxidation, nitrosation, thiolation and 
sulfidation (also termed “sulfhydration”). Therefore, rather than “on/off” switches, protein 
cysteines may act as multistage cysteine relays (Fig. 3), allowing cells to dynamically adjust 
rotein structure and enzymatic function according to the local redox state (100,216). In 
addition to protein thiols, low-molecular-weight thiols including cysteine and glutathione are 
important contributors to intracellular and, via mixed disulfide formation, possibly also 
extracellular redox status (Fig. 5). In order to function as regulatory elements, those thiol-
based post-translational modifications must be also under kinetic control. This is achieved by 
coupling cysteine-based modifications to a battery of target-specific reductases, 
denitrosylases, and desulfurases which together are able to maintain steady-state 
concentrations of thiol modifications low; these include thioredoxin/thioredoxin reductase, 
glutaredoxin, peroxiredoxins and other enzymes (68). Both thiol modifications and their 
regeneration are dynamically linked to global redox and nutritional status (see Section 4, and 
Fig. 1). 
3.5 Biological targets of the RSI 
The net biological effects of the reactive species are determined by the nature, level 
of expression and function of the biological targets carrying functional cysteine redox 
switches (Box 1 and Fig. 1). Examples include protein kinases and phosphatases, ion 
channels, transporters, and enzymes (e.g. those involved in intermediary metabolism), 
allowing rapid short-term adjustments (Fig. 1). In addition, longer-term regulation is achieved 
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by interaction with redox-sensitive transcription factors, e.g. Nrf2/Keap1, NFkb, and HIF (54). 
Even longer-persisting effects are achieved by redox regulation of gene expression under 
epigenetic control, making redox effects transmissible to the progeny. This notion is 
consistent with the developmental origin of health and disease (DOHaD) paradigm, which 
provides a mechanistic explanation for the pathophysiological basis of how environmental 
influences experienced during early embryonic development may influence the risk of non-
communicable diseases later in life and across generations (71,77,217)(see also Section 6). 
3.6 Functional significance of the RSI 
A corollary of the RSI concept is that reactive species can no longer be regarded as mere 
stressors (Box 1). Rather, they should be considered controlled reaction products, which 
serve to sense and transduce information about any changes of internal and/or external 
conditions; as such they may be considered as elements of a regulatory system (the RSI) 
that enable an integrated response to various forms of stress, e.g. changes in metabolic, 
nutritional and redox status, and environmental conditions (Box 4). See also Boxes  1, 2, 
and 5.   
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4. RSI precursors in the context of intermediary 
metabolism and nutrition 
The RSI is driven by specific substrates for enzymatic production of individual ROS, 
RNS and RSS. Local production of reactive species depends on the availability of O2, certain 
amino acids and cofactors as well as the activity of specific enzymes, which together are 
embedded within an intricate system of intermediary metabolism that determines the pattern 
and rate of fluxes according to synthetic and energetic needs (Fig. 4). Given the 
fundamental role redox regulation plays in cellular defense, repair and survival, the balance 
of metabolic fluxes must be prioritized to first support an adequate redox status before 
fulfilling local metabolic needs.  The following section provides a short overview of the 
precursors needed for ROS, RNS and RSS synthesis in the context of dietary intake and 
human nutrition (Fig. 4). 
4.1 Precursors of ROS, RNS and RSS – The oxygen-arginine-methionine metabolome 
Unsurprisingly, in aerobic organisms oxygen sensing is intimately linked to 
intermediary metabolism (1). ROS production involves a variety of different enzymes and 
organelles utilizing oxygen, but the relationship is not straightforward; counter-intuitively, 
more mitochondrial O2y− is produced in hypoxia than under normoxia (207). O2 is also the 
substrate of various NADPH oxidases producing either O2- or H2O2 (16,199). Other sources 
include xanthine oxidoreductase, 5-lipoxygenase and cytochrome P450. Non-enzymatic ROS 
production may also be generated in an unregulated fashion through the metal-driven 
Haber-Weiss reaction leading to the formation of OHy. Enzymatic generation of NO requires 
both a source of N and O, specifically in the form of arginine (and possibly homoarginine) 
and O2 (72,127,167), whereas NOS-independent reactions leading to NO formation include 
nitrite/nitrate reduction (43,90,116,172,192). NOS activity is also dependent on 
tetrahydrobiopterin and reducing equivalents in the form of NADPH (72,185). RSS 
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production relies on the availability of methionine, homocysteine and cysteine serving as 
substrates in the methionine recycling and transsulfuration pathway. The enzymes of the 
ranssulfuration pathway are responsible for the formation of cysteine from the essential 
amino acid methionine and serine. Cysteine is crucial for defining protein structure (disulfide 
bonds), function (e.g. enzymatic activity) and redox signaling (e.g. by acting as redox 
switches, see Section 3), and as a building block for glutathione (GSH) production. The 
tripeptide GSH (Glu-Cys-Gly) is less toxic for cells than cysteine itself, is present in 
millimolar concentrations intracellularly and buffers the cellular antioxidant network, together 
with ascorbate (vitamin C), ubiquinol (coenzyme Q) and α-tocopherol (vitamin E) (175). The 
two other amino acids critical to GSH synthesis are glycine (itself in part derived from serine) 
and glutamine (formed from glutamate and interaction with proline) (see Suppl. Fig.1). 
Cofactors like folate, choline, vitamin B6 (pyridoxal phosphate) and B12 (cobalamin) 
are critically important for adequate methionine recycling. Interestingly, several metabolic 
aberrations in either the tetrahydrofolate cycle, the methionine recycling capacity, or flux 
through the transsulfuration pathway are associated with elevated homocysteine 
concentrations in blood. The latter marks metabolic imbalance and/or inadequate nutrient 
availability, and hence is a marker of risk for cardiovascular disease (95,138). The 
transsulfuration pathway enzymes cysteine-β-synthase (CBS), cysteine-γ-lyase (CSE) and 
3-mercaptosulfotransferase (MST) are also responsible for the endogenous production of 
H2S (144) as well as organic persulfides (CBS) (86) and polysulfides (3-MST)(101,102). 
CBS is functionally regulated by NO, its expression enhanced by oxidative stress and gene 
transcription hormonally regulated in response to fuel supply (182). These pathways 
therefore can be considered to be a central hub for intermediary metabolism and a point of 
intersection for the production of proteins (as building block for tRNA and ribosomal protein 
synthesis), lipids (via S-adenosylmethionine and choline), methylation reactions (via S-
adenosylmethionine) as well as GSH production and H2S/persulfide signaling. This is in 
accordance with the recent discovery that the nearly 4 billion year old metabolism of the last 
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universal common ancestor (LUCA), the forerunner of all contemporary life forms on Earth, 
already relied on S-adenosylmethionine-dependent 1-carbon metabolism to make a living by 
harnessing energy from its primordial geological environment (208). 
The interaction of H2S, NO and O2 is tightly linked to bioenergetics through their 
convergence in the regulation of mitochondrial function. In cultured cells, hypoxic stress 
induces CSE translocation from the cytosol to mitochondria to sustain ATP production, 
resumably via fine-tuning of the electron transport chain and use of sulfide as a 
mitochondrial substrate (63,78,188). Marked changes in metabolic needs and/or 
mitochondrial function are likely to affect precursor/cofactor availabilities and therefore RSI-
mediated sensing and adaptation processes (Box 5). 
4.2 How nutrition affects precursor availability 
4.2.1  L-Arginine uptake and metabolism in the human body 
In addition to its role in protein biosynthesis, arginine is a precursor for creatine and 
NO production. There is the need for endogenous formation of arginine, and for young, 
growing mammals it has to be provided in the diet (i.e. it is an essential amino acid), but less 
so in adulthood, where it can be considered to be conditionally essential. (189). Inadequate 
availability of arginine has been associated with T-cell and endothelial dysfunction (129); 
these effects are not usually observed in healthy adults (24) as endogenous synthesis is 
sufficient to meet usual demands, except in situations of catabolic stress (e.g. inflammation 
or infection) (128). The net rate of endogenous de novo arginine synthesis is modulated in 
relation to provision from the diet and the breakdown of proteins (28).  
There is evidence for de novo synthesis of arginine in enterocytes up to the age of 3-
5 years (202,212). Beyond this, a more complex inter-organ amino acid cooperativity is 
required, which involves enterocytes and the renal cortex (14,48,213) (known as the 
intestinal-renal axis). In enterocytes, endogenous and dietary glutamine is converted into 
 Page 24 of 71
An
tio
xid
an
ts 
& 
Re
do
x S
ign
ali
ng
Th
e R
ea
cti
ve
 Sp
ec
ies
 In
ter
ac
tom
e: 
Ev
olu
tio
na
ry 
Em
erg
en
ce
, B
iol
og
ica
l S
ign
ifi
ca
nc
e, 
an
d O
pp
ort
un
itie
s f
or 
Re
do
x M
eta
bo
lom
ics
 an
d P
ers
on
ali
ze
d M
ed
ici
ne
 (d
oi:
 10
.10
89
/ar
s.2
01
7.7
08
3)
Th
is 
art
icl
e h
as 
be
en
 pe
er-
rev
iew
ed
 an
d a
cc
ep
ted
 fo
r p
ub
lic
ati
on
, b
ut 
ha
s y
et 
to 
un
de
rgo
 co
py
ed
itin
g a
nd
 pr
oo
f c
orr
ec
tio
n. 
Th
e f
ina
l p
ub
lis
he
d v
ers
ion
 m
ay
 di
ffe
r f
rom
 th
is 
pro
of.
25 
25 
A
nt
io
xi
da
nt
s a
nd
 R
ed
ox
 S
ig
na
lin
g 
Th
e 
R
ea
ct
iv
e 
Sp
ec
ie
s I
nt
er
ac
to
m
e:
 
Ev
ol
ut
io
na
ry
 E
m
er
ge
nc
e,
 B
io
lo
gi
ca
l S
ig
ni
fic
an
ce
, a
nd
 O
pp
or
tu
ni
tie
s f
or
 R
ed
ox
 M
et
ab
ol
om
ic
s a
nd
 P
er
so
na
liz
ed
 M
ed
ic
in
e 
 (d
oi
: 1
0.
10
89
/a
rs
.2
01
7.
70
83
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is
 p
ro
of
. 
citrulline via glutamate and ornithine (218). Circulating citrulline is then taken up by cells in 
the renal cortex and converted into arginine (14,48,213). The conversion of arginosuccinate 
o arginine, the final step in arginine de novo synthesis, requires arginosuccinate lyase 
(ASL), which is almost exclusively found in the renal cortex. Hepatic arginine synthesis is 
embedded in the metabolic pathway of the urea cycle and therefore results in high flux but 
low net production (218). 
Approximately 60% of net arginine synthesis occurs in the kidney. However, renal 
insufficiency does not result in decreased plasma arginine concentration, but in increased 
itrulline levels (112,218). The mechanisms underlying the maintenance of plasma arginine 
concentration are poorly understood, but may involve a compensatory decrease in arginine 
utilization (28).  
Only a small proportion (~1%) of the overall arginine turnover but a considerable 
amount (54%) of circulating arginine is used for NO production (27). In healthy human 
adults, the production of NO from L-arginine corresponds to ~1 mmole/day (173). Citrulline, 
one of the products of NOS, can be recycled by transamination to arginine via the so-called 
“citrulline/NO cycle” or “arginine/citrulline cycle” (76,218), although in vitro this cycle is much 
less efficient than the hepatic urea cycle (218). Of note, the guanidino nitrogen group used 
to form NO is mostly not derived from dietary arginine, but from carbamoylphosphate and 
aspartate (see Suppl. Fig.1). 
Arginine moieties in proteins can be methylated to form mono- and dimethylated 
derivatives, which are released into the circulation upon proteolysis. Circulating 
concentrations of two of these methylated arginine derivatives (L-NG-methylarginine and 
asymmetric, but not symmetric dimethylarginine) are effective inhibitors of cellular arginine 
uptake and NOS activity (113). While symmetric dimethylarginine does not act as direct 
NOS inhibitor it can reduce NO production by competing with arginine transport (13).. 
4.2.3. Methionine recycling, transsulfuration and one-carbon metabolism 
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Methionine and cysteine are the two sulfur-containing amino acids (SAA) 
incorporated into proteins. Methionine is one of the most hydrophobic amino acids.  It has 
important physiological roles including the initiation of translation via initiation tRNA (met-
tRNAimet) and methylation pathways via S-adenosylmethionine (18,182), which are important 
for the formation of co-factors such as biotin and lipoic acid. Despite its importance in 
physiology and being the 7th most abundant element in higher vertebrates, the extent to 
which the dietary provision of sulfur-related components adequately supports the needs of 
sulfur metabolism has received inadequate attention (87,134).  
The main sources of sulfur in the diet are inorganic sulfate (SO42-) and SAAs. 
Methionine can be converted into cysteine, and with a sufficient supply of the former, 
dequate amounts of the latter can be formed endogenously from serine. However, as this 
reaction is irreversible, methionine has to be provided preformed in the diet regardless of 
cysteine status (152). Dietary methionine is absorbed rapidly and almost completely and 
only small amounts are excreted directly following bolus administration. It is eliminated from 
plasma with a half-life of approximately 150 minutes, and a 3-fold increase in urinary SO42-, 
another important product of transsulfuration (85). 
Healthy adults are in sulfur balance with equilibrium between intake, transsulfuration 
and excretion. The conversion of methionine to cysteine via homocysteine, is the only 
catabolic pathway of methionine. Sulfur is excreted via the kidney mainly as free sulfate 
(SO42-, 77% – 92%), esterified sulfate (7% – 9%), taurine (2% – 6%), cyst(e)ine (0.6 – 0.7% 
and minor amounts of methionine, homocysteine, cystathionine, N-acetylcysteine, 
mercaptolactate, mercaptoacetate, thiosulphate and thiocyanate (182). The net changes 
represented by external balance do not adequately capture the considerable internal flux 
associated with the turnover of methionine and cysteine into and from protein and peptide 
pools, estimated as 32 mmol and 38 mmol per day, respectively (19). Although the daily 
production of H2S has not been quantified it is likely considerably higher than that of NO. 
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Homocysteine represents a determinant branch point for methionine flow either to 
cysteine through transsulfuration via pyridoxal-phosphate dependent CBS and CSE to 
cystathionine and cysteine, or re-methylation via betaine, folate or vitamin B12 (cobalamin) 
dependent pathways (89,177) (Fig. 4 and Fig. S1). Under physiological conditions, there is a 
similar flow through each pathway (183), but changes in methionine supply or the relative 
availability of donors for methylation modify the flow through these pathways. Low 
methionine availability results in high transsulfuration rates (presumably secondary to 
systemically increased ROS production), whereas a replacement of methionine by cysteine 
results in increased re-methylation (49). Importantly, modulation of dietary SAA intake can 
affect plasma redox status (93). 
Methionine homoeostasis is achieved by modulation of the balance of protein 
turnover and the relative rates of transsulfuration and re-methylation (64,151,152,183). The 
reductive adaptations developed during malnutrition limit the capacity for handling large 
doses of methionine leading to a high plasma concentration of methionine (178) and  
increased concentration of homocysteine (88).  Similar to poor vitamin B6 status and limited 
serine availability perturbations in amino acid status can result in homocysteine 
accumulation, increased re-methylation to methionine and a concomitant reduction in flux 
through the transsulfuration pathway. Overall, methionine maintains a very stable plasma 
concentration at the expense of endogenous sulfate production (87).  
4.2.4 The sulfur / nitrogen relationship 
In adults consuming a normal diet there is a strong correlation between urinary 
sulfate and dietary sulfur-containing amino acid intake, and urinary S:N ratio reflects dietary 
S:N ratio (157,171). This relationship is however modulated by unusual dietary patterns, for 
example during starvation or on low-protein diets when post-prandial urinary sulfate 
excretion is reduced to a greater extent than urea excretion (74,97,118,119). This suggests 
that protein restriction results in preservation of SAA and replenishment of the non-protein 
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SAA pool, but also complex and tight interconnections between the metabolic pathways of 
nitrogen and sulfur metabolism to maintain constant plasma concentrations of methionine. 
Thus, alterations in the S:N ratio of urinary metabolites may hold promise as indicators of a 
stressed system with unusual metabolic demands. 
4.3 Impact of microbial-host co-metabolism on components of the RSI  
Besides the above mammalian pathways, H2S may also be generated from 
isothiocyanates, which are particularly prevalent in Brassica vegetables such as broccoli 
(23,32), polysulfides contained in garlic (7), and via gut microbial reduction of dietary sulfate 
(SO42−) (23), cysteine and protein (23,119). Microbial H2S generation may contribute to the 
total body pool of sulfide (170) and may even have blood pressure lowering effects (191). 
Likewise, dietary nitrite and nitrate can be reduced by the oral and gut microbial flora to NO, 
contributing to circulating nitrite levels and mildly lower blood pressure (25,117); together 
with the enterosalivary recirculation pathway this has become known as the mammalian N-
oxide cycle (25,116). It is conceivable that a similar sulfur cycle exists in mammalian 
organisms and those pools of H2S and NO may give rise to reactive species, including 
ONOO− and possibly SSNO− (37,39,41). Fluctuations in intestinal oxygen gradients may 
further shape the redox relationships between the gut microbiome and the host metabolome 
(53). 
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5.   Inter-organ redox communication systems  
One of the primary functions of the circulatory system in mammals is to efficiently 
transport oxygen, nutrients and waste products around the system. With one exception (136) 
little consideration has been given to its further potential role in acting to communicate and 
maintain whole-body redox status in relation to external environmental conditions and 
internal metabolic needs .  
Individual cells within a given tissue/organ need to sense their microenvironment in 
relation to that of the entire organism in order to achieve a metabolic status that adequately 
enables the needs of their preferred activity (Box 4). Similarly, the cells need to relate their 
individual redox status within a composite redox state that matches with other cells and 
organs. This necessitates reciprocal sensing of intra- and extracellular redox poise.  This 
has to embrace cell membrane behavior, and an inter-organ communication system that 
connects the various contributing elements and provides a read-out of the global redox 
poise. Extracellular fluids such as interstitial fluid, lymph and blood are especially well suited 
as the connecting medium (36). We propose that the entirety of protein thiols serves as an 
important redox buffer and that extracellular thiol status helps to mark the global redox state 
in health and disease. 
5.1 Quantifying “oxidative stress”: early attempts 
In vitro, oxidative stress is typically assessed by determining the concentration of 
reduced/oxidized glutathione, antioxidant enzyme (SOD, catalase, glutathione peroxidase) 
activity and/or the levels of (anti)oxidants and the potential for free radical scavenging using 
fluorescent molecules with all their limitations (205), including their lack of specificity for ROS 
vs. RSS (47). More often than not, little distinction is made between assessing capacity to 
cope with an oxidant burden, determining the magnitude of exposure to an oxidant, and the 
balance between exposure and antioxidant capacity. Earlier attempts at quantifying oxidative 
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stress in vivo by measuring levels of select products of lipid, protein or DNA oxidation (e.g., 
8-isoprostanes, malondialdehyde, protein carbonyls, 8-hydroxyguanosine) often met with 
disappointment in that all these biomarkers showed distinct profiles scaling with oxidative 
stress burden but considerable temporal heterogeneity. The reason for this divergence is not 
i mediately apparent, and is likely due to the fact that some “markers” are only bystanders 
of oxidative damage, while others are actual regulatory nodes of the antioxidant network. 
Insights into the system architecture of the redox network and its modus operandi are 
required to interpret this information. Valuable insight might be derived from information 
about metabolic fluxes (the direction of travel within metabolic pathways), which can be 
achieved by either applying stable isotope labeling methodology or monitoring natural 
isotopic fractionation using high-sensitivity, high-resolution mass spectrometry (“fluxomics”).  
5.2 Assessment of low molecular weight and protein thiols in plasma/serum 
Based upon the assumption that thiols play a determinant role in redox regulation, 
measuring the ratio of reduced over oxidized forms of small aminothiols such as cysteine or 
glutathione is potentially more powerful than measuring levels of individual oxidation 
products inasmuch as it informs us about the status of a dynamic system that serves to 
shuttle nutrients between cells/organs and electrons between the intracellular and 
extracellular milieu. Often misunderstood, it is not the electrochemical redox potentials (of 
e.g. GSH/GSSG) that drive the biology; those concentration ratios are simply the outcome of 
fast enzymatic processes related to thiol transport, degradation and regeneration (57). The 
ratios of reduced/oxidized thiols show diurnal variation (12) and decrease with age, but the 
redox couples of cysteine and glutathione, for example, are not in equilibrium (92). This 
indicates that ratios are maintained at defined levels, which might be presumed to confer 
benefits that are as yet unclear. However, even those measurements reflect only a small 
part of the overall thiol redox network, as it fails to capture the large protein-bound thiol pool 
(196) and kinetically controlled exchange reactions with free thiols in the intra- and 
extracellular compartment. While the overall complexity of this system has been appreciated 
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already some time ago (196), little is known about central regulatory nodes governing these 
equilibria. 
A recent report suggests that cysteine and glutathione redox status are associated 
with mortality from coronary artery disease (143). Another highly significant association was 
found between total free thiol status in serum and clinical outcome in unrelated clinical 
conditions (61,105). Given the overall complexity of the extracellular antioxidant network and 
its link to intracellular redox status the latter was utterly unexpected. A simplistic view of total 
free thiol levels in a given compartment could be interpreted as a direct reflection of the 
balance between oxidants and antioxidant capacity (or overall redox poise). Indeed, a 
decrease of reduced thiols and/or an increase of oxidized thiols has been found in patients 
with blood disorders, cancer, cardiovascular disease, diabetes, inflammatory disease, kidney 
disease, metabolic disease, neurological disease, skin disease and thyroid disease 
(3,108,110,123,133,180,220). Thiol oxidation has also been associated with risk factors, 
including aging, smoking, obesity and alcohol abuse (69). Both within cells (75) and in blood 
(195), proteins constitute by far the largest pool of redox-active thiols. Approx. 60% of the 
total thiol groups in serum/plasma are accounted for by the single free cysteine (Cys34) of 
albumin (195). Thus, when instead of the ratio of free and oxidized thiols only free thiols are 
measured, adjustment for total serum protein can be seen as an indirect way of accounting 
for total thiol content.  
In renal transplant recipients, protein-adjusted serum free thiols were found to predict 
graft failure and patient survival (61,105). In a small cohort of stable chronic heart failure 
patients there was a positive association between protein-adjusted serum free thiols and a 
favorable disease outcome (61,105). Interestingly, a study evaluating the concentration of 
serum protein thiols in a wide range of species concluded that free thiol levels are positively 
associated with life span, suggesting that control of redox status has retained its importance 
from evolution to modern-day (patho)physiology (146).  
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Studies relating serum free thiol levels to other components of the redox network are 
lacking. In this context, disentangling the relationship between overall thiol redox status (free 
reduced and oxidized as well as protein-bound thiols), which is likely affected by cellular 
uptake and reduction processes, and production/metabolism of both NO and H2S/sulfide 
would seem to be important. We here propose that protein thiols in the extracellular fluid 
play a fundamental role in communication between different body compartments, acting as 
sentinels of distant danger, transporters of specific substrates and as dynamic entities that 
reflect a readout of global thiol redox status. Rather than relying on the integrity of a single 
protein to fulfill this important function, there is greater security with greater buffering 
capability and in Nature the entire protein thiol pool may play a role for this purpose. 
Nevertheless, albumin is likely to play a more important role quantitatively, simply based on 
its abundance in the extracellular compartment (195) and the extent to which it transports 
small aminothiols. While mixed disulfide formation can occur non-enzymatically via attack of 
reactive protein thiolates (e.g. Cys34 of albumin) at the disulfide bond of oxidized thiols, the 
reverse process that would regenerate the free thiol is very slow. This implies that a 
significant portion of these reactions must be controlled through the activity of specific thiol 
oxidoreductases such as glutaredoxin, protein disulfide isomerase, and 
thioredoxin/thioredoxin reductase (70). Besides mixed disulfide formation (S-thiolation), 
other sulfhydryl modifications including S-nitrosylation, S-sulfuration (“sulfhydration”), S-
oxidation, and S-acylation (e.g. S-palmitoylation) may also reversibly decrease free thiol 
availability, but information on the practical relevance of these processes is limited. This may 
be particularly relevant for cysteinylation and persulfidation of protein thiols as micromolar 
concentrations of per/polysulfides were detected in biological tissues (86) and therefore 
have the potential to affect the measurement of total free thiols. 
 
5.3 Intracellular redox regulation, bioenergetics and intermediary metabolism 
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The same fundamental regulatory principles that operate in the extracellular 
compartment likely apply to intracellular redox state (Fig. 5). Much emphasis has been 
devoted to the process of S-cysteinylation and S-glutathionylation (46,66), although other 
posttranslational modifications may be of similar importance. Cross-talk between cell 
compartments of widely different redox status (nucleus, endoplasmic reticulum, 
peroxisomes, mitochondria) is of significance in this context (30,51,161), since the same 
reactive species that modulate mitochondrial activity and dynamics (130,211) may also link 
overall redox poise to intracellular signaling, metabolic control and bioenergetic status (188). 
Mitochondrial dysfunction has recently been demonstrated to remodel one-carbon 
metabolism (4), and the latter is fundamental for mammalian health and disease (50). 
These regulatory principles would provide the opportunity to prioritize options for 
metabolic adjustments in individual cells in relation to the overall redox status of the 
organism, which might be achieved as a consequence of exchange of redox information 
across cell membranes (Fig. 5). Although the cystine/glutamate antiporter has been 
implicated (34) the elements connecting intra- and extracellular space to exchange this 
nformation are currently unknown.  An effective communication across cell membranes 
requires moieties that reliably operate under widely different redox conditions, i.e. under 
oxidative as well as reductive stress. There are limited choices chemically that fulfill the need 
of electron exchange under those extremes, but one interesting possibility may involve the 
persulfide/perthiyl radical couple (10). 
5.4 Redox state and cell survival 
Redox status is also linked to cell survival (193,222). Effective repair of damage is 
cardinal to survival and resilience. DNA repair mechanisms have been studied most 
extensively, not least because the survival of organisms depends on faithful transmission of 
genetic information from one cell to the next (and across generations), from the level of DNA 
replication over chromosomal distribution to the repair of damage incurred. This involves 
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surveillance systems for structural monitoring and orchestration of the sophisticated repair 
processes during normal functioning (31). Spontaneous DNA lesions are common events 
(82), and the response to DNA damage is principally orchestrated through activation of 
sensors, transducers and effectors.  This allows to resolve problems induced by physical or 
chemical stresses while limiting unnecessary maintenance. Several DNA repair enzymes 
including poly ADP-ribose polymerase are under redox control (3), which may provide a 
mechanistic explanation for the observed association between plasma free thiols and active 
disease. Similar processes are at work under conditions of strong emotional stresses, which 
are known to be associated with oxidative stress, poor immune function and health, lower 
telomerase activity and telomere shortening (52). These observations are akin to what 
happens during normal ageing, just at a higher pace. Thus, life stresses of any sort, 
perceived or real, seem to lead to accelerated (premature) ageing. Since parallel monitoring 
of multiple stresses is energetically costly, integrated stress sensing will be a preferred 
option; bacteria realize this through distributed sensing of metabolic fluxes (106). A sizeable 
portion of an organism’s energy is spent processing sensory information (162), which 
enables stress tolerance: as the ability of cells to generate adequate levels of energy 
declines, housekeeping and acute repair processes are compromised and physiological 
function starts failing. 
 
6. Perspective: How redox biology and insights into the 
regulation of the RSI may transform personalized 
medicine. 
The regulatory concepts outlined above, as viewed from the perspective of systems 
biology, may provide useful guidance in any search for prevention and treatment 
approaches in the emerging area of redox medicine. Based upon the notion that 1.) a set of 
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factors plays a dominant role in sensing environmental changes (O2, amino acid substrates 
around the arginine-methionine metabolome and its cofactors), 2.) another set of factors 
acts as transducing elements (cysteine-based redox relays and the dynamic interplay of free 
reduced and oxidized, and protein-bound thiols), and that 3.) there are stable end products 
of the RSI (S,N,O-based stable metabolites), it is possible to create a conceptual framework, 
which places the complexities of these interactions into context and allows to interrogate the 
quality and quantity of the balance of forces amongst the different components. The 
specificity of this approach will be guided not by pre-defined levels of normality of particular 
read-outs (as commonly practiced in current medicine), but rather by understanding what 
determines the metabolic fluxes through these pathways (Fig. 6). Due to the interacting 
nature of the pattern and direction of flow through many pathways within a complex system, 
he nature and outcome of these interactions will differ depending upon context and 
ircumstance from individual to individual.  This underlies the basis of personalized medicine 
and indicates the diagnostic basis needed to develop rational therapeutic interventions that 
adequately meet the individual situation (Box 6). In the following, we will present our 
understanding of redox regulation in the context of health and disease, suggest methods to 
interrogate the activity status of its components and how to utilize these insights for the 
benefit of a personalized medicine approach. 
6.1 What defines health?  
Contemporary medicine still uses the same organ-based classification system physicians 
developed centuries ago to define disease symptoms. We have become better and better at 
treating diseases, but not necessarily at identifying the root cause of illness or just “feeling 
sick” (166). More often than not ‘disease’ itself is equated with dysfunction. The converse is 
our limited ability to define and measure what constitutes health. In medical diagnostic terms 
it often means staying within perceived limits of the distribution of variations in simple 
physiological readouts (such as blood pressure, heart rate, peripheral oxygen saturation, 
white blood count etc.) and the absence of overt signs of organ/tissue damage. Systems 
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biology has taught us much about the emergence of unpredicted states arising from the 
complex interaction of multiple, non-linear interconnected systems, and these lessons are 
now being incorporated into what constitutes systems medicine. To this end, good health is 
not merely a state defined by the absence of overt symptoms of disease, but includes overall 
ental and physical wellbeing and resilience to stress. Biomarkers of good health are in 
short supply and limited to a few markers of nutritional adequacy (e.g. amino acid, protein 
and micronutrient status) and perceived levels of normality of markers associated with 
nflammation, oxidative stress cell aging (telomere length) and DNA methylation. However, 
the latter two tend to differ markedly between individuals and ethnicities and provide limited 
information about the origin of the problem or the reserve capacity of the regulatory systems 
affected. From a systems perspective, as long as an organism is alive, one can consider its 
sub-systems to be functioning; however, perturbations may force them to deviate from their 
normal equilibria and setpoints. If severe enough, these perturbations may become obvious 
and observable as disease phenotype (e.g. elevated blood pressure, hyperglycemia), which 
may be interpreted as the price paid by the organism to stay fully operational. To this end, 
accelerated aging (and aging per se) may be viewed as a process that leads to a 
compromised capacity for repair and/or adaptive change, eventually culminating in system 
failure and death (217) 
6.2 Personalized medicine 
Personalized medicine aims at providing individually tailored prevention and 
treatment strategies for patients. One important driver for this development is the realization 
that generic treatment approaches are not optimally addressing patients’ needs. With an 
ageing population and ever-rising healthcare costs the idea is to provide tailored solutions 
matched to specific deviations from the desired equilibrium with the aim to improve 
population health. In the words of the Horizon2020 Advisory Group personalized medicine is 
"a medical model using characterization of individuals’ phenotypes and genotypes (e.g. 
molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy 
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for the right person at the right time, and/or to determine the predisposition to disease and/or 
to deliver timely and targeted prevention" (see 
https://ec.europa.eu/research/health/index.cfm?pg=policy&policyname=personalised). The 
fascination with this concept transcends medicine as it goes well beyond the treatment with 
edical products to include a better understanding of how particular biological mechanisms 
and interactions of our body with environmental, nutritional and infectious stresses (known 
as the ‘exposome’ (210)) affect health and disease along the life course. How can these high 
expectations be fulfilled?  
6.3 Targeted redox metabolomics for understanding disease processes 
Great methodological strides have been made in recent years to capture the entirety of 
genetic and transcriptomic events in an affordable manner. Beyond the use of multiple 
‘omics’ techniques for deep phenotyping, however, a sound understanding of the key drivers 
and mechanisms underlying disease processes and resilience is required. Importantly, the 
mere integration of genomics, transcriptomics and proteomics does not provide any 
information about enzyme function/activity and metabolic pathways. Metabolomics, i.e. the 
analysis of stable products of metabolic pathways, may offer a deeper level of information 
about the state of an organ or the entire organism, and may therefore be a key enabling 
technique for personal/precision medicine (6). Much of the recent success of metabolomic 
approaches is linked to the rapid advancement in mass spectrometry-based techniques over 
the last two decades, but many technical obstacles are still to overcome to extend the level 
of coverage typical of genomic approaches to metabolic events. Measuring the entire 
metabolome of every patient may remain beyond reach for some time, but a targeted 
approach covering key aspects appears realistic even today.  
Despite the advancements in untargeted metabolomics to identify and analyze 
complex patterns of metabolites, some of the low-abundance, polar or volatile metabolites 
still pose analytical challenges; in particular, many of the highly reactive species of fleeting 
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existence, as for example H2S and its per- and polysulfides belonging to the RSI, are 
currently only reliably quantifiable after chemical trapping, providing more stable derivatives 
(86,99). A disadvantage of such approaches is that they tend to perturb natural equilibria, 
not only complicating the interpretation of changes recorded but also introducing bias as 
their disappearance can elicit adaptive reactions not normally seen under physiological 
conditions.  
6.4 What to measure where and how? 
To adequately capture the substrates utilized by the RSI for sensing and transduction 
processes, we propose to concentrate on those parts of intermediary metabolism that are 
central to the regulation of redox status and production of essential building blocks of life 
such as DNA/RNA, vitamins, amino acids/proteins and fatty acids/lipids. Emphasis should 
be placed on integrative biomarkers faithfully reporting on multiple mechanisms operating in 
synchrony. Circulating homocysteine concentrations are a pertinent example as they 
represent a combined read-out of methionine and vitamin B6/12 availability, one-carbon 
metabolism (methionine recycling and tetrahydrofolate pathways), and flux through the 
transsulfuration pathway, an ancient pathway established almost 4 bya (208); there may well 
be many more among the markers we routinely asses today. Thus, besides capturing as 
many species as possible around these pathways to monitor bodily sulfur/SAA handling and 
H2S production the arginine metabolome will be another sensible target to capture as it 
provides insight into nitrogen handling and NO-related processes. To describe the dynamics 
of the thiol regulatory system, we suggest quantifying the entirety of free and protein-bound 
thiols; differences in concentration of stable end-products of the RSI in different 
compartments may serve as readouts of the sensing and adaptation system in operation. 
For sulfur hydrosulfide, per- and polysulfides, thiosulfate and sulfate would seem to be 
useful readouts, complemented by ammonium, urea, nitrite, nitrate, nitroso and nitrosyl 
species for the nitrogen products. Relevant, clinically accessible compartments to analyze 
include blood (plasma and cellular components), saliva, sweat, urine and exhaled breath. 
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To gain insight into the regulation of the entire system whole-body responses to 
various stressors ought to be explored first in healthy individuals subjected to e.g. exercise 
vs. rest, hypoxia vs. normoxia, heat vs. cold, fasting vs. controlled feeding, and exposure to 
frequently prescribed or over-the-counter drugs such as anti-inflammatories. This will form 
the basis for subsequent interrogations in diseased individuals and patients on specific drug 
regimens and allow disentangling the underlying redox network architecture using specific 
patient cohorts. Once we understand how the system is structured, organized and able to 
sense in a way that enables control and regulation we will be in a position to intervene 
causally to achieve defined objectives. 
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7 Summary and outlook: Disentangling the RSI using 
redox metabolomics to enable precision medicine 
The interactions between individual constituents of the RSI and key biological targets 
of the antioxidant network are complex. Hoping to disentangle the in vivo relationships for 
the benefit of defining treatment opportunities for redox medicine will require quantifying 
stable decomposition products and downstream metabolites of RSS, RNS and ROS 
interaction, along with their substrates, in multiple biofluids, in health and disease. Since we 
are not dealing with ‘on/off reactions’, it would be naive to expect that measuring a few 
biomarkers in health and comparing them to levels one observes in overt disease would 
suffice. The perils of oversimplification are nowhere more apparent than in the interpretation 
of circulating homocysteine concentrations (197). To capture the dynamics of regulation, we 
ught to measure the same set of readouts in healthy individuals of different sex/age under 
varying levels of physiological perturbation, (sedentary/exercise, normoxia/hypoxia, 
starved/fed, etc.) and compare their steady-state levels under these conditions to 
concentrations in sex/age-matched patients suffering from specific diseases. By carefully 
matching the physiologic/metabolic phenotypes to the profile of biochemical markers we 
should be able to learn enough to decode the underlying network architecture. In turn, this 
will enable us to identify new avenues for targeted therapeutic modulation of redox signaling. 
Besides guiding pharmacological treatments, those insights may also aid risk-stratifying 
patients before undergoing major surgery, improve recovery from critical illness or major 
trauma and inform nutritional priorities for healthy ageing. 
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Table captions  
 
Tab. 1 Definition of terms. Scientific terms used in the text and marked in italics. 
 
Tab. 2 Chemical Attributes of ROS, RNS and RSS (interactions with metals and 
metalloproteins not included in this overview) 
 
 
 
 
Figure legends 
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Fig. 1 – Intracellular, extracellular and inter-organ/systemic role of the RSI. Precursors of the 
RSI are organic and inorganic substrates and cofactors including amino acids (e.g., arginine, 
methionine), vitamins (B6, B12, C), xanthine as well as oxygen, nitrite, polysulfides, thiosulfate and 
sulfate, which are transformed by mitochondrial or cytoplasmic enzymes into reactive oxygen species 
(ROS), reactive nitrogen species (RNS) and reactive sulfur species (RSS).  The chemical interactions 
among ROS, RNS and RSS lead to formation of a number of products with different reactivities, 
stabilities, half-lives, and therefore different lifetimes defined by their physicochemical properties, 
covering a wide range of maximal travel distances. A common target of the RSI are cysteine thiols in 
proteins, acting as redox switches, able to fine-tune activity of signaling molecules and leading to 
short-term responses (e.g., protein kinases and phosphatases inducing changes in signaling and 
glucose metabolism) or long-term adaptation (by modifying redox switches responsible for gene 
expression regulation, like the HIF, NFkB, and Keap-1/Nrf2 pathways). The RSI serves also as a local 
and systemic heterocellular communication system mediated by actions of longer-lasting products of 
the RSI (e.g. nitrite, polysulfides) and circulating thiols. The nutritional and physiological status of the 
rganism affects the RSI by reciprocally regulating precursor availability, metabolism, signaling and 
mitochondrial function. (To see this illustration in color the reader is referred to the web version of this 
article at www.liebertonline.com/ars) 
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Fig. 2 – Evolution of sulfur and oxygen metabolism. The lines indicate fluctuations in 
concentration of atmospheric oxygen (blue) and oceanic sulfide (orange) over evolutionary times. 
Atmospheric O2 was essentially absent from the environment at the onset of life ca. 3.8 billion years 
ago (bya). After the great oxidation event (GOE) the concentration of O2 in the atmosphere increased, 
which was accompanied by a substantial increase in H2S. The first eukaryotes appeared in oceans 
and developed in anoxic and sulfidic (euxinic) conditions for hundreds of millions of years using sulfur 
as their energy source, producing RSS. During this time, defense mechanisms against RSS evolved 
mproving cell survival and minimizing the need for repair of damaged cell constituents. Appearance 
of oxygenic cyanobacteria and plants lead to increases in O2 levels and oxidation of H2S and Fe2+ 
approximately 0.6 bya. Those changes were accompanied by a significant decrease in dissolved H2S 
and a repurposing of enzymatic systems that originally evolved to protect organisms against RSS to 
serve additional antioxidative protective functions. Mass extinctions (*, percentage of marine and land 
life) were often associated with a fall in ambient O2 and increases in H2S, perhaps providing a 
biological filter for descendants that retained some degree of tolerance to hypoxia and sulfide. 
Modified with permission from Olson & Straub (139). (To see this illustration in color the reader is 
referred to the web version of this article at www.liebertonline.com/ars) 
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Fig. 3 – Cysteine modifications induced by the interaction with reactive oxygen, nitrogen and 
sulfur species. The reactive species interactome consists of the interaction of reactive species 
(ROS, RNS, RSS) with one another and with cysteine thiols as redox switches (reactions with other 
functional groups omitted here for the sake of simplicity). The outcome of these interactions depends 
on the chemical characteristics of the species inducing the modification (e.g. O2 −, H2O2, NO, ONOO-) 
and their fluxes, the environmental conditions (e.g. pO2, pH) as well as on the reactivity and 
localization of the targeted cysteines. The lines indicate the outcome of protein cysteine modifications 
induced by RNS (blue), ROS (red) or RSS (orange). (To see this illustration in color the reader is 
referred to the web version of this article at www.liebertonline.com/ars) 
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Fig. 4 – Metabolic pathways fuelling the RSI.  In mammals, L-arginine is formed from citrulline, 
derived either from dietary glutamine or proline via ornithine and carbamoylphosphate in the 
mitochondria, or from bicarbonate (HCO3-) and ammonia (NH3) via the hepatic urea cycle. Citrulline is 
then transported via the blood to the kidney where it is converted into arginine. Arginine used for 
protein formation and (O2-dependent) NO synthesis can be recycled via the arginine/citrulline cycle. 
NO synthase activity is inhibited by different methylated arginine residues released by proteolysis 
(e.g. ADMA, asymmetric dimethylarginine). A key interaction between nitrogen and sulfur metabolism 
is the methylation of arginine using S-adenosyl-methionine (SAM)-dependent methyltransferases. 
SAM is a cofactor produced from methionine and used for the methylation of a large number of 
biomolecules; in the methionine recycling pathway, the removal of one methyl group (-CH3), resulting 
in the formation of homocysteine. Depending on the availability of methionine, homocysteine is either 
recycled to methionine with the help of vitamin B12 and folic acid, or is degraded to cystathionine and 
cysteine. While the latter also serves as precursor of cellular glutathione production both compounds 
can generate H2S in the transsulfuration pathway. Not shown here is the formation of ROS via 
NADPH oxidases, the mitochondrial respiratory chain and other sources. See Supplementary Fig. 1 
for more details. (To see this illustration in color the reader is referred to the web version of this article 
at www.liebertonline.com/ars) 
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Fig. 5 – Thiol transport between cell organelles and exchange between the intra- and 
extracellular compartment. In human plasma, aminothiols such as cysteine, homocysteine and 
glutathione exist in free (reduced and oxidized) and protein-bound form, but little is known about the 
dynamics of their regulation and relationship with each other. As documented for cysteine and 
glutathione, aminothiols are transported across cell membranes and exchanged between cell 
rganelles, with specific transporters such as the cysteine (CysSSCys)/glutamate (Glu) antiporter 
(Xc), which plays an important role in the regulation of cell surface redox. Continuous arrows indicate 
known relationships, interrupted arrows represent unknown relationships. In both the intracellular and 
extracellular compartment protein thiols represent the main pool of sulfhydryl (-SH) groups. (Note that 
ifferent font sizes in the figure denote relative concentrations and that mixed disulfides of low-
molecular-weight thiols and post-translational thiol modifications are omitted here for the sake of 
simplicity.) The cytosol is considerably more reduced compared to the extracellular space or the 
endoplasmatic reticulum (where proper protein folding requires more oxidizing conditions). The redox 
couples cysteine/cystine, GSH/GSSG and protein bound thiols are not in equilibrium with each other, 
which suggests the involvement of specific enzyme systems that determine the steady-state levels of 
these species. Maintaining dysequilibria requires energy, and energy tends to be allocated according 
to criteria that confer robustness of organisms along the evolutionary selection process. First steps 
into the direction of decoding what determines ATP utilization hierarchies at a systems level are being 
taken, but the mechanisms of regulation of systemic thiol/disulfide status remain largely obscure. 
Considering the inverse association of free thiols with risk of death, a further assessment of these 
relationships and their significance for the cellular stress responses, DNA repair processes and other 
hard clinical endpoints seems to be justified. However, no number of observational studies will ever 
be able to establish causality; this will require prospective and interventional studies. (To see this 
illustration in color the reader is referred to the web version of this article 
at www.liebertonline.com/ars) 
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Fig. 6 – Simplified scheme visualizing the consequences of a reduced redox buffering capacity 
(“redox reserve”) due to bioenergetic limitations. Under normal physiological conditions, 
extracellular redox poise is subject to diurnal variations, fluctuating between more reducing (-) and 
more oxidizing (+) conditions (12). The capacity of a cell/organism to deal with changes in reductive 
and oxidative load is intimately linked to mitochondrial function. Enhanced mitochondrial activity is 
associated with higher oxidative stress, which affects the redox status of the local tissue 
microenvironment, while the activity of the mitochondrial respiratory chain itself and mitochondrial 
intermediary metabolism are modulated by the local and global redox status (upper cartoon). An 
adequate bioenergetic reserve capacity allows redox stresses (oxidative stress induced by e.g., 
strenuous physical activity or reductive stress due to chronic overfeeding) into either direction to be 
comfortably accommodated without incurring damage to cellular constituents (upper panels); 
physiological redox fluctuations experienced in daily life situations are well within the normal buffering 
capacity. Mitochondrial dysfunction leads to impaired cellular bioenergetics, resulting in a narrowing of 
a cell’s or an organism’s ability to buffer redox stresses, inflicting damage and/or compromising 
adaptive capacities (middle panels), which can result in severe impairment of redox regulatory events 
upon further bioenergetic challenge (lower panels). Under these conditions, significant damage may 
be inflicted (shaded areas), demanding the allocation of additional energy to cellular repair processes. 
According to these relationships, chronic stress triggers a vicious cycle that can lead to a condition 
associated with severely limited redox reserve capacity, compromising cellular surveillance and repair 
mechanisms and inviting cascading network failures. This notion is consistent with the links of AMP-
activated protein kinase and aberrant mitochondrial gene expression with cellular stress, 
aging/degenerative processes and immune processes (186), molecular systems energetics (159,160) 
in general, and the emerging concept of bioenergetic health, where redox biology controls the 
interface between bioenergetics, autophagy and circadian control of metabolism (209)(29). See also 
Box 6. (To see this illustration in color the reader is referred to the web version of this article 
at www.liebertonline.com/ars) 
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Tab. 1    
Term Definition References 
Stress and Adaptation  
Stress / adaptation 
to stress 
the term stress, as used in the biomedical literature, was coined by Hans 
Selye in the 1930s, who defined it as “the non-specific response of the 
body to any demand for change”. 
(166) 
Cellular stress 
response 
a set of cellular responses (including the down-regulation of protein 
synthesis and up-regulation of transcription factors involved in defense 
and repair mechanisms) common to all eukaryotes aimed at coping with 
various forms of stress; also known as “integrated stress response” 
(141,150) 
Hormesis beneficial effects of low levels of stress (“what does not kill us makes us 
stronger”” 
(121) 
Redox Chemistry and Biology 
Oxidative stress an imbalance between oxidants and antioxidants in favour of the 
oxidants, leading to a disruption of redox signaling and control and/or 
molecular damage  
(176) 
Reactive species  compounds with high chemical reactivity produced enzymatically or non-
enzymatically; the interaction of reactive species may produce other 
reactive species 
(73) 
Reactive oxygen 
species (ROS) 
chemically reactive compounds derived from oxygen  
Reactive nitrogen 
species (RNS) 
chemically reactive compounds originating from the reaction of nitric 
oxide with oxygen or oxygen-derived compounds 
 
Reactive sulfur 
species (RSS) 
according to Jacobs et al produced by “toxification” of thiols by reactive 
oxygen and nitrogen species, including disulfide-S-oxides, sulfenic acids 
and thiyl radicals and predicted to modulate the redox status of biological 
thiols and disulfides; more recently, RSS were discussed as putative 
regulatory entities of biological significance 
(67,126) 
Reactive species 
interactome (RSI) 
chemical interaction of RSS, RNS and ROS (possibly including other 
short-lived species to be discovered in the future) among themselves and 
with downstream biological targets. The RSI is characterized by a) high 
variability/adaptability; b) rapid responsiveness; c) flexibility, which is 
required for fine-tuning of biological functions and communication at 
multiple levels; and d) high redundancy (explaining why antioxidants do 
not work) 
This review 
Redox regulation a term used to define the control of redox signalling  (176) 
Redox code a set of principles that defines the positioning of the nicotinamide adenine 
dinucleotide (NAD, NADP), thiol/disulfide and other redox systems as 
well as the thiol redox proteome in space and time in biological systems 
(94) 
protein thiol 
switches 
thereby switching the protein between different conformational and 
functional states 
Personalized and Redox medicine 
Personalized 
medicine 
health care that is tailered on iduvidual condition, needs and life-style ( in 
contrast to one-size-fits-all approach) 
 
Precision medicine health care that is tailored on the basis of an individual’s genes, lifestyle 
and environment 
(81) 
Stratified medicine a therapy that is targeted to a specific patient population on the basis of a 
clinical characteristic such as a biomarker that predicts treatment 
response 
(194) 
Redox medicine / 
redox diseases 
diseases with involvement of aberrant redox regulation/processes 
ranging from oxidative to reductive stress 
(26,206) 
P4 medicine predictive, personalized, preventive and participatory (P4) medicine. P4 
medicine is fueled by systems approaches to disease, emerging 
technologies and analytical tools 
(84) 
Developmental 
origins of health 
and disease 
a paradigm affirming that environmental influences experienced during 
early embryonic development may influence the risk of non-
communicable diseases later in life and across generations  
(77) 
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Table 2 
 
 
Species   Occurrence/Formation     Chemistry 
Dioxygen, O2  aerobic life  Has unpaired electrons - reacts readily with other radicals, poor 1e- 
oxidant but otherwise easily reduced by 2,3 and 4e-.  
Box 2 – The RSI in sensing, signaling and adaptation to stress – Principles of 
regulation in the context of origins of life, evolution and adaptation 
Organisms observed today represent a snapshot of now – i.e. a cross-sectional view 
encompassing historical experience of preferred life forms that survived past evolutionary 
stresses, are compatible with the prevailing environment and fit for purpose. Assuming the 
overarching biological purpose is reproduction, this requires faithful replication of complex 
structures and molecular forms, which need to be dynamic yet sufficiently stable to assure 
structural and functional integrity of the system as a whole.  
Biological flexibility in response provides resilience to all sorts of stressors in a constantly 
changing environment and can be identified at all levels of organization, which can be rationalized 
in terms of mathematics (networks), (bio)physical, (bio)chemical, physiological principles, as well 
as individual behavior and function, group behavior, and social realities on a global scale.  
Influenced by Claude Bernard’s concept of the “milieu interieure” and Walter Cannon’s 
notion of homeostasis, the term stress was coined by Hans Selye in the middle of the last century; 
using experimental animal models, Selye also observed that persistent stress could lead to the 
development of various diseases (166). Mechanisms enabling to cope with stress are crucial 
checkpoints for resilience. Adaptation to (perceived or real) environmental, nutritional, life-style 
related or mental stresses serves the purpose to improve the fitness of a biological organism to 
deal with those stresses in the future. The concept of hormesis describes the ability of small 
stresses to confer protection via activation of the cellular stress response (121), a universal 
defence reaction of cells to damage to cellular macromolecules (107). 
Providing biological flexibility requires energy, which is derived from the release of 
chemical energy in food to produce heat, readily available forms of energy (e.g., ATP, creatine 
phosphate) and reducing equivalents (NAD(P)H); reacting to specific shortages in energy supply 
requires metabolic plasticity; and adjusting metabolism appropriate to the prevailing conditions 
requires a sensing and adaptation system. Resilience against stress also demands coupling of 
the sensing elements to appropriate protection and repair systems that provide a first line-of-
defense (in the form of e.g. antioxidants/antioxidant enzymes) and a system that can identify, 
repair or excise damage to biomolecules or tissues caused by endogenous reactive species or 
exogenous toxicants. Thus, effective buffering against potentially harmful conditions and/or 
environmental threats requires all four: sensing, adaptation, defense and repair systems working 
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Superoxide, O2-  1e- reduction of O2  Has one unpaired electron. Good reductant.  Under 
acidic conditions can be an oxidant.  Reacts with other radicals. 
Hydrogen peroxide, H2O2 1e- reduction of O2-  Two-electron oxidant. Electrophilic. Not a radical species. 
Can modify RSH (below).  
Hydroxyl radical, HO· 1e- reduction of H2O2 Potent 1e- oxidant.  A short-lived radical species capable 
of abstracting an e- or hydrogen atom from most biological molecules.   
 
Nitric oxide, NO  enzymatic, NO2- reduction Has unpaired e-. Poor oxidant.  Reacts with other radicals (O2 and 
O2- and other organic radicals (R·)).  Can quench radical chemistry. 
Nitrogen dioxide, NO2 oxidation of NO  Good 1e- oxidant.  Radical species. Reacts with other 
radicals (can make R-NO2 when reacted with R·).    
Dinitrogen trioxide, N2O3 oxidation of NO by O2  Not a radical. Electrophilic and can nitrosate nucleophiles 
(add equivalent of “NO+”).  Synthesis only relevant at high concentrations of NO. 
Peroxynitrite, ONOO- reaction of NO and O2- Not a radical but can generate both HO· and NO2. 
Rearranges to give nitrate (NO3-). Can oxidize by 2e- (via peroxide-like chemistry).   
Nitroxyl, HNO  S-nitrosothiol reduction Reacts readily with thiols.  A good hydrogen atom donor.  
Can act as an anti-oxidant by quenching radical reactions. 
Nitrite, NO2-  oxidation of NO, dietary Unreactive at neutral pH.  Not a radical. Nitrosating agent 
under acidic conditions.  Can be reduced to NO (under acidic conditions).  
 
Hydrogen sulfide, H2S geochemical, enzymatic Good metal ligand.  Not a radical.  Can react with other 
biological electrophilic sulfur species (e.g. RSSR, RSOH).  
Thiol, RSH  endogenous (e.g. cysteine) Good metal ligand.  Not a radical.  Can be oxidized to 
give other biologically relevant sulfur species. 
Thiyl radical, RS·  1e- oxidation of RSH  Radical species.  Good 1e- oxidant.  Will react 
with other radical species such as NO.  
Disulfide, RSSR  oxidation of RSH  Not a radical.  Electrophilic.  Can be reduced back to 
RSH under biological conditions. 
S-Nitrosothiols, RSNO Nitrosation of RSH  Not a radical.  Can be reduced to RSH and HNO.  Can 
transfer “NO+” to another thiol (transnitrosation). 
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Sulfenic acid, RSOH 2e- oxidation of RSH Not a radical.  Electrophilic (reacts with other thiols to 
give disulfides, RSSR).  
Hydropersulfide, RSSH enzymatic  Not a radical.  Superior nucleophile and can be 
electrophilic (akin to RSSR).  Good 1e- reductant.  Readily reduced back to RSH. 
Hydropolysulfide, RSSnH oxidation of RSH  Properties similar to RSSH (although enhanced in all 
aspects).  
Dialkyl polysulfide, RSSnR oxidation of RSH  Properties similar to RSSR (althought enhanced in all 
aspects).  Can also be nucleophilic. 
ONSS-   unknown, to be determined Fairly stable.  Appears to be a source of NO. Chemical 
properties pending.  
ONS-   unknown   Fleeting.  Chemical properties pending. 
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Box 1 – The reactive species interactome (RSI) 
The reactive species interactome (RSI) is a redox system consisting of chemical 
interactions of RSS, RNS and ROS among themselves and with downstream biological targets.  
The RSI is characterized by a) robustness and flexibility; b) adaptability; c) rapid 
responsiveness; d) ability to sense the environment; and e) the ability to transduce signals that are 
required for fine-tuning of biological functions and communication at multiple levels.  
The richness of chemical products of the RSI affords the unique redundancy and flexibility 
of the system. The products of the RSI are continually generated by enzymatic reactions and are 
as varied as the chemistries of the reactive species themselves. Chemical interactions of the RSI 
include one- and two-electron oxidations, nitrosation, nitration and sulfuration/polysulfidation 
reactions. Each of the species of this interactome has a distinct reactivity and lifetime that is 
defined by its physicochemical properties (65), and by environmental conditions (such as 
temperature, pH, pO2), covering a wide range of maximal travel distances and thus action radii 
(35,79,215). 
Being a product of regulated enzymatic transformation of nutrients (amino acids and 
inorganic substrates such as nitrite, sulfate etc.) the RSI allows rapid adjustment to changes in 
environmental conditions (e.g. by post-translational modifications), as well as long-term adaptation 
by regulation of gene expression. It thereby serves an integrative function to sense and transduce 
multiple stressors, adjust bioenergetic/metabolic needs and activate downstream effector 
pathways to ensure the organism stays fit for purpose.  
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Box 3 – The RSI in sensing, signaling and adaptation to stress – Principles of 
regulation in the context of origins of life, evolution and adaptation 
Organisms observed today represent a snapshot of now – i.e. a cross-sectional view 
encompassing historical experience of preferred life forms that survived past evolutionary 
stresses, are compatible with the prevailing environment and fit for purpose. Assuming the 
overarching biological purpose is reproduction, this requires faithful replication of complex 
structures and molecular forms, which need to be dynamic yet sufficiently stable to assure 
structural and functional integrity of the system as a whole.  
Biological flexibility in response provides resilience to all sorts of stressors in a constantly 
changing environment and can be identified at all levels of organization, which can be rationalized 
in terms of mathematics (networks), (bio)physical, (bio)chemical, physiological principles, as well 
as individual behavior and function, group behavior, and social realities on a global scale.  
Influenced by Claude Bernard’s concept of the “milieu interieure” and Walter Cannon’s 
notion of homeostasis, the term stress was coined by Hans Selye in the middle of the last century; 
using experimental animal models, Selye also observed that persistent stress could lead to the 
development of various diseases (166). Mechanisms enabling to cope with stress are crucial 
checkpoints for resilience. Adaptation to (perceived or real) environmental, nutritional, life-style 
related or mental stresses serves the purpose to improve the fitness of a biological organism to 
deal with those stresses in the future. The concept of hormesis describes the ability of small 
stresses to confer protection via activation of the cellular stress response (121), a universal 
defence reaction of cells to damage to cellular macromolecules (107). 
Providing biological flexibility requires energy, which is derived from the release of 
chemical energy in food to produce heat, readily available forms of energy (e.g., ATP, creatine 
phosphate) and reducing equivalents (NAD(P)H); reacting to specific shortages in energy supply 
requires metabolic plasticity; and adjusting metabolism appropriate to the prevailing conditions 
requires a sensing and adaptation system. Resilience against stress also demands coupling of 
the sensing elements to appropriate protection and repair systems that provide a first line-of-
defense (in the form of e.g. antioxidants/antioxidant enzymes) and a system that can identify, 
repair or excise damage to biomolecules or tissues caused by endogenous reactive species or 
exogenous toxicants. Thus, effective buffering against potentially harmful conditions and/or 
environmental threats requires all four: sensing, adaptation, defense and repair systems working 
in concert to confer protection, offer stability and offset damage. The RSI is involved in sensing / 
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Box 4 – Chemical biology and functional significance of the RSI. 
ROS were initially viewed as mere by-products of redox reactions, especially 
mitochondrial respiration and certain pathological conditions, leading to oxidative damage of 
biological targets (protein, lipids, DNA). Further oxidative reactions were believed to be mediated 
by RNS, mainly produced by the oxidation of NO. Similarly, cysteine oxidative modification and 
formation of RSS were first considered only as a consequence of pathological conditions (67). 
Today, reactive species are considered part of a complex redox signaling network that interacts 
with protein thiol targets, which act as redox switches to control protein structure and function in 
dependence of local and global redox and environmental/nutritional status. The analysis of the 
chemical biology of H2S and related sulfane sulfur species, and their interaction with NO and ROS 
indicate that the RSI is a tightly intertwined redox network that enables rapid sensing and 
adaptation of the internal cellular milieu to a changing environment. As indicated in Box 1 it is 
noteworthy that this redox metabolic network appears to have evolved in a world dominated by 
sulfur and only later incorporating the wider range of options involving nitrogen and oxygen 
species. This is exactly the opposite order as to how these species were discovered and 
discussed as contributors to redox biology in the literature. The basis of the interactions among 
the reactive species in the RSI are defined by the fundamental chemistries of their atomic 
constituents. However, in order to be able to operate effectively and enable regulatory control, the 
system also requires an ability to sense, respond and adapt to the prevailing state. This is 
achieved by subjecting both formation and elimination of reactive species and their downstream 
metabolites to kinetic control through the activity of specific enzymes. 
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Box 5 – RSI precursors and cofactors  
The precursors and cofactors required to support the functioning of the RSI belong to the 
oxygen-arginine-methionine metabolome and originate from the same pathways that provide the 
basic building blocks for proteins, lipids, methyl groups, DNA/RNA synthesis and are thus 
important for cell proliferation and repair; this suggests competition between anabolic events and 
redox signaling. The RSI also regulates the expression and activity of enzymes belonging to 
intermediary metabolism and stress response, highlighting the interactions between catabolism, 
bioenergetics and redox status. The reciprocal nature of these relationships indicates that RSI 
serves as a central hub that integrates intermediary metabolism and stress signaling (Fig. 1). In 
addition, tissue/organ functions need to be coordinated and integrated for the sake of optimal 
fitness of the entire organism; this is achieved via a central communication system, i.e. the blood, 
transporting gases, nutrients, waste products as well as immune cells and platelets. Considering 
the fundamental role of the blood in maintaining systemic homeostasis, the RSI itself may 
participate in systemic redox regulation (See also Section 5).   
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Box 6 – Chemical biology of the reactive species interactome - The long and winding road 
from evolution to personalised medicine  
The challenge of developing a dynamic map of redox interactions is related to placing the 
fundamental chemistry within a given physiological process or disease mechanism into spatial and 
temporal context. Although the RSI concept begins disentangling the fundamental interplay 
between the different reactive species and their biological targets, before their use in personalized 
medicine specific mechanism-based biomarker panels need to be developed. To this end, the 
evolutionary origin of redox regulation based fundamentally on the handling of various sulfur 
species may provide a useful pointer since “Nature does not waste a good chemical reaction”.  
A case in point is nitrogen fixation and nitrate/nitrite reduction to make NO. Bacteria can produce 
NO either via ammonia oxidation (e.g. Nitrosomonas) or denitrification (e.g. Pseudomonas), giving 
rise to NO emanations from soil; plants use NO to stimulate cyclic GMP. Nitrite reductase is a 
P450-like enzyme that evolved into a NO synthase (NOS) using another source that connects 
important proliferative and immune responses to arginine metabolism. This evolution helps today’s 
mammalian organisms regulate host defense mechanisms via modulation of mitochondrial 
respiration and intermediary metabolism (affecting bioenergetics and immunometabolism). 
The ultimate thermodynamic equation that connects evolution with precision medicine is that 
describing Gibbs free energy: ∆G = ∆H-T∆S where the fundamental reactions of small molecules 
depend mostly on ∆H or the energy of covalent bond making.  However, in the biological context 
∆S means there are ever-increasing differentiated states/niches defined by the process of 
evolution.  Precision medicine is by definition where ∆H meets ∆S. To get there involves a series 
of approximations: 1st the ∆H of the fundamental chemical reactions (section 3); 2nd the interaction 
of the reactive species metabolome with macromolecules; 3rd cellular compartmentalization; 4th 
tissue interactions; 5th systemic physiological and inflammatory; 6th is the genomic and epigenetic 
interaction with these processes; and 7th the interaction between macroorganisms and 
microbiome, virome and exposome (210). 
Thermodynamics can tell us into which direction redox reactions may proceed, but it cannot tell us 
anything about their speed or indeed whether those reactions can ever be fast enough to be of 
biological significance. Overcoming energetic barriers by using substrate-specific enzymatic 
catalysis is an important first step, but just the beginning. Redox tunes systems through reaction 
rates (affecting concentrations), timing, and location - these factors provide precise targets that in 
Nature are exploited to improve biological fitness.  The challenge is to unveil how this chemical 
redox biology operates in health and disease using multi-biomarker analysis (via “omics”) and 
imaging tools to determine location and timing. Such redox mapping will hold the key to novel 
therapeutics. 
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Supplementary figure legend 
 
Supplementary Fig. 1: Metabolic pathways fuelling the RSI.  In adult mammals, L-arginine is 
formed either via the entero-renal axis from dietary glutamine or proline, or via the hepatic urea 
cycle. Enterocyte mitochondria form citrulline from proline and glutamine via ornithine and 
carbamoylphosphate, and export it to the kidney where it is converted into arginine. The hepatic 
urea cycle also uses ornithine and carbamoylphosphate as precursor for arginine synthesis. As 
in enterocytes, the formation of carbamoylphosphate, from ammonia and bicarbonate, and 
citrulline synthesis takes place in the mitochondria. Arginine used for NO synthesis can then be 
recycled via the arginine/citrulline cycle. NO synthase activity is inhibited by different methylated 
arginine species (ADMA, NMA), which themselves are precursors for arginine biosynthesis via 
citrulline. A key interaction between nitrogen and sulfur metabolism is the methylation of arginine 
using SAM-dependent methyl transferases. SAM is formed from methionine and used for the 
methylation of a large number of different molecules, resulting in the formation of homocysteine 
(Hcy). Depending on the availability of methionine, homocysteine is either recycled to methionine 
via vitamin B12 and folate-dependent methionine synthase or betaine-homocysteine S-
methyltransferase (BHMT), or is degraded to cystathionine, cysteine and H2S via the 
transsulfuration (TS) pathway. 
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